(ACRI-B) Acrinova Series - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015660030
ACRI-B: Warehouses, Offices, Logistics, Residential Properties
Acrinova AB (publ) is a Swedish real estate company specializing in the ownership, development, and management of a diversified property portfolio. Its assets include residential units, commercial spaces such as shops and restaurants, and industrial properties like warehouses and production facilities. The company, established in 2014 and headquartered in Malmö, operates across multiple sectors, including office premises, gyms, and preschool facilities. Acrinova focuses on strategic acquisitions and property enhancements to drive long-term value creation. Web URL: https://www.acrinova.se
As of the latest data, Acrinova AB Series B (Ticker: ACRI-B) trades on the Stockholm exchange with a market capitalization of 597.90M SEK. The stock has shown a price-to-book ratio of 0.63, indicating its assets are valued below book value. Its price-to-earnings ratio stands at 67.08, reflecting high valuation relative to earnings. The companys return on equity is 1.05, signaling modest profitability. The average trading volume over 20 days is 7,374 shares, with a last price of 9.48 SEK. Technical indicators show the stock trading above its 20-day SMA (8.86) and 50-day SMA (9.02), but closely aligned with its 200-day SMA (9.04). The Average True Range (ATR) of 0.25 highlights low volatility in recent trading.
3-Month Forecast: - Technical Outlook: The stock is expected to remain stable, trading near its 200-day SMA with limited upside due to low volatility (ATR: 0.25). Support levels are likely to hold around the 50-day SMA (9.02), with resistance near 9.75. - Fundamental Outlook: With a P/B ratio below 1, the stock may attract value investors. However, the elevated P/E ratio (67.08) suggests caution, as it reflects high expectations for future earnings growth. The low average volume (7,374 shares) could limit liquidity and increase price sensitivity to large trades.Additional Sources for ACRI-B Stock
ACRI-B Stock Overview
Market Cap in USD | 74m |
Sector | Real Estate |
Industry | Real Estate - Diversified |
GiC Sub-Industry | Real Estate Operating Companies |
IPO / Inception |
ACRI-B Stock Ratings
Growth 5y | 3.33% |
Fundamental | 19.4% |
Dividend | 21.9% |
Rel. Strength | 48.7 |
Analysts | - |
Fair Price Momentum | 10.91 SEK |
Fair Price DCF | 7.71 SEK |
ACRI-B Dividends
Dividend Yield 12m | 3.00% |
Yield on Cost 5y | 2.95% |
Annual Growth 5y | -6.29% |
Payout Consistency | 84.5% |
ACRI-B Growth Ratios
Growth Correlation 3m | 22.3% |
Growth Correlation 12m | 53.5% |
Growth Correlation 5y | -39.5% |
CAGR 5y | 1.85% |
CAGR/Max DD 5y | 0.03 |
Sharpe Ratio 12m | -0.09 |
Alpha | 49.33 |
Beta | 0.425 |
Volatility | 32.69% |
Current Volume | 51.8k |
Average Volume 20d | 3.8k |
As of April 09, 2025, the stock is trading at SEK 10.95 with a total of 51,824 shares traded.
Over the past week, the price has changed by +16.00%, over one month by +24.15%, over three months by +20.33% and over the past year by +51.09%.
Neither. Based on ValueRay Fundamental Analyses, Acrinova Series is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.38 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACRI-B as of April 2025 is 10.91. This means that ACRI-B is currently overvalued and has a potential downside of -0.37%.
Acrinova Series has no consensus analysts rating.
According to ValueRays Forecast Model, ACRI-B Acrinova Series will be worth about 11.8 in April 2026. The stock is currently trading at 10.95. This means that the stock has a potential upside of +7.67%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.8 | 7.7% |